Constraint-induced movement therapy in stroke rehabilitation: Perspectives on future clinical applications

被引:6
作者
Blanton, Sarah [1 ]
Wilsey, Heather [2 ]
Wolf, Steven L. [1 ]
机构
[1] Emory Univ, Sch Med, Div Phys Therapy, Ctr Rehabil Med, Atlanta, GA 30322 USA
[2] Habersham Cty Med Ctr, Demorest, GA 30535 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Results from studies supporting the application of constraint-induced movement therapy (CI therapy) in patients with stroke have steadily increased over the past decade. The exploration of this intervention has provided a broad foundation from which to build further development of evidence-based practice in neurorehabilitation. This article first provides an update on CI therapy efficacy based on the relative chronicity of stroke and the functional levels of participants from whom data have been acquired. A review of current considerations is discussed, including guidelines for screening criteria, the role of the patient and family during the intervention, options for various delivery modes and suggestions to monitor outcomes. Finally, future directions are explored through identification of integrated approaches with CI therapy including: robotics, virtual environments, mental imagery, pharmaceutical manipulations and cortical stimulation. Clinical application of a research based intervention should not occur in isolation. CI therapy researchers should be charged to define the critical aspects of this therapy and appropriate adjunctive interventions that augment its applicability and effectiveness.
引用
收藏
页码:15 / 28
页数:14
相关论文
共 104 条
[1]
Adams K J, 1999, J Cardiopulm Rehabil, V19, P209, DOI 10.1097/00008483-199907000-00001
[2]
Bach F.R., 2002, J MACHINE LEARNING R, V3, P1
[3]
Late postacute neurologic rehabilitation: Neuroscience, engineering, and clinical programs [J].
Bach-y-Rita, P .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2003, 84 (08) :1100-1108
[4]
A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke [J].
Bakheit, AMO ;
Thilmann, AF ;
Ward, AB ;
Poewe, W ;
Wissel, J ;
Muller, J ;
Benecke, R ;
Collin, C ;
Muller, F ;
Ward, CD ;
Neumann, C .
STROKE, 2000, 31 (10) :2402-2406
[5]
SELF-EFFICACY - TOWARD A UNIFYING THEORY OF BEHAVIORAL CHANGE [J].
BANDURA, A .
PSYCHOLOGICAL REVIEW, 1977, 84 (02) :191-215
[6]
Bayona Nestor A, 2005, Top Stroke Rehabil, V12, P58
[7]
Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial [J].
Bhakta, BB ;
Cozens, JA ;
Chamberlain, MA ;
Bamford, JM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (02) :217-221
[8]
BLANTON S, 2005, 3 STEP C SALT LAK CI
[9]
Constraint-induced movement therapy during early stroke rehabilitation [J].
Boake, Corwin ;
Noser, Elizabeth A. ;
Ro, Tony ;
Baraniuk, Sarah ;
Gaber, Mary ;
Johnson, Ruth ;
Salmeron, Eva T. ;
Tran, Thao M. ;
Lai, Jenny M. ;
Taub, Edward ;
Moye, Lemuel A. ;
Grotta, James C. ;
Levin, Harvey S. .
NEUROREHABILITATION AND NEURAL REPAIR, 2007, 21 (01) :14-24
[10]
Bonifer N, 2003, PHYS THER, V83, P384